Solid-phase peptide synthesis lives or dies at the coupling step, where the choice of condensation agent sets the balance between activation speed, racemization, and side reactions. This article compares carbodiimides, benzotriazole additives, phosphonium and uronium salts, phosgene derivatives,…
There is no universal condensation coupling reagent for solid-phase peptide synthesis SPPS . The right choice depends on the amino acid being activated, the resin, the protection scheme, and the sequence context, and the reagent that minimizes racemization for one coupling can be the wrong tool for the next. Four properties govern the decision: activation efficiency, suppression of side reactions, compatibility with the resin and the other reaction components, and solubility in the reaction solvent.
SPPS is the standard route to peptides of many lengths and sequences, with applications from pharmaceutical development to structural biology. The C-terminal amino acid is loaded onto an insoluble resin, and the chain is built by repeated deprotection and coupling cycles with washes between them. After the final coupling, side-chain protecting groups are removed and the peptide is cleaved from the resin. The coupling step is the critical one: forming a peptide bond requires the incoming amino acid's carboxyl group to be activated into a species reactive enough for the resin-bound amine to attack. Condensation agents do that activation, and they are the main variable the synthetic chemist controls.
The short answer to the practical question is conditional. For routine resin-based couplings, start with a carbodiimide, preferably DIC , combined with an equivalent amount of HOBt . That combination is inexpensive, mild, and racemization-suppressed. When steric hindrance or a difficult sequence defeats it, the specialist reagents described below take over. The rest of this article explains the chemistry behind those choices and states where the evidence is qualitative rather than quantitative.
A free carboxyl group is a poor acyl donor. Its hydroxyl is a mediocre leaving group, and under the basic conditions needed to keep the incoming amine nucleophilic the carboxyl exists largely as the carboxylate, which is even less electrophilic. Activation converts the carboxyl into a reactive intermediate the amine can attack directly: an O-acylisourea from a carbodiimide, an OBt or OAt ester from benzotriazole-based reagents, a phosphonium or uronium species, an acyl chloride or carbonate from phosgene derivatives, or a mixed anhydride. The price of activation is that the same reactive intermediate can react with itself instead of with the amine.
The main self-destruction route is racemization through oxazolone formation . When a carbamate-protected amino acid is activated, the protecting group's carbonyl oxygen can close a 5 4H -oxazolone ring on the activated carboxyl. The ring's α-proton is acidic; once removed and replaced, the residue is a mixture of epimers, and coupling through the oxazolone fixes the epimer into the chain. Fast, selective activation shortens the lifetime of the species that can form oxazolones, which is why additive design matters as much as activation speed.
Side chains create a second class of problems. Activated carboxyls can dehydrate the primary amides of asparagine and glutamine to nitriles, a reaction known to occur with carbodiimide activation. Activated species can also rearrange to unreactive N-acylureas, wasting the amino acid and lowering yield. These are the side reactions that reagent selection is meant to control, and they explain why so many reagents exist: each one trades a different set of risks.
The protection scheme constrains the choice before any reagent is weighed. Reactive side chains must be protected by groups that survive the repeated N-terminal deprotection. In the Boc/Bzl combination, Boc is removed under mild acid such as 50% TFA in DCM, while benzyl-type side chains require very strong acid such as HF or TFMSA; because both are acid-sensitive, this pair is not truly orthogonal, and selectivity rests on acid strength. In Fmoc/tBu chemistry the Fmoc group comes off with base and tert-butyl-type side chains with acid, which is genuinely orthogonal. A reagent that attacks the resin linkage or the side-chain protecting groups is disqualified regardless of its coupling speed.
The carbodiimides DCC N,N'-dicyclohexylcarbodiimide , DIC N,N'-diisopropylcarbodiimide , and EDCI 1-ethyl-3- 3-dimethylaminopropyl carbodiimide hydrochloride, also called EDC are among the most widely used condensation agents; they can convert carboxylic acids into amides, esters, and anhydrides. The mechanism is a single addition. The carboxyl attacks one of the carbodiimide's two equivalent carbons to form an O-acylisourea, and the amine then attacks that intermediate to release the peptide bond and a urea by-product.
The by-product's solubility decides which carbodiimide suits which format. DCC gives dicyclohexylurea, nearly insoluble in most organic solvents, which precipitates; DCC therefore suits solution-phase reactions where the urea can be filtered off. DIC gives diisopropylurea, which stays in solution, so DIC is preferred for resin-based SPPS, where precipitated solids would block the resin frit and reduce yield. EDCI and its urea by-product are water-soluble and can be removed by water washes, which makes EDCI the common choice for protein modification and other water-washable applications.
Used alone, carbodiimides have real limitations. The source warns that carbodiimide activation can convert primary amides into nitriles, citing aspartic and glutamic acid residues as a hazard; the better-documented substrates for that dehydration are the side-chain amides of asparagine and glutamine. Activation can also rearrange to unreactive N-acylureas, and incomplete activation creates side products. The standard fix for racemization is to add an equivalent amount of HOBt 1-hydroxybenzotriazole . HOBt intercepts the O-acylisourea to form a 1-hydroxybenzotriazole ester, a less frantic acyl donor that couples quickly with far less racemization. The source describes carbodiimides as relatively inexpensive, easy to handle, broadly applicable, and effective under mild conditions, and mild conditions themselves reduce racemization pressure. The families covered in this article line up by activated intermediate, by-product, and niche as follows.
| Reagent | Activated intermediate | Characteristic by-product | Principal niche |
|---|---|---|---|
| DCC | O-acylisourea | Dicyclohexylurea, precipitates | Solution-phase couplings |
| DIC | O-acylisourea | Diisopropylurea, soluble | Routine resin couplings, with HOBt or Oxyma |
| EDCI | O-acylisourea | Water-soluble urea | Water-washable systems, protein modification |
| BOP | OBt ester | Hexamethylphosphoramide, carcinogenic | Asn/Gln-rich sequences, SPPS |
| PyBOP | OBt ester | Pyrrolidino phosphoramide, lower risk | BOP-like efficiency without HMPA |
| PyAOP | OAt ester | Pyrrolidino phosphoramide | N-methyl-protected amino acids |
| PyBrOP | Acyl bromide-type species | Pyrrolidino phosphoramide | N-methyl and α,α-dialkyl amino acids |
| BOP-Cl | Phosphinic mixed anhydride | Oxazolidinone | Fmoc-α,α-dialkyl amino acids on tritylphenyl resin |
| TBTU | OBt ester via uronium species | Tetramethylurea | Fast couplings, difficult sequences |
| Triphosgene | Acyl chloride and carbonate esters | HCl, CO2 | Challenging amino acids, specialized handling |
Benzotriazole derivatives work by stabilizing the active ester intermediate. BOP , one of the first alternative reagents developed to generate OBt esters in situ, is described in the source as not dehydrating asparagine or glutamine side-chain amides to nitriles and as causing minimal racemization, a real advantage over plain carbodiimide activation. Its flaw is the by-product: BOP generates hexamethylphosphoramide HMPA , which is highly carcinogenic and demands careful handling. PyBOP delivers comparable condensation efficiency with a lower-risk by-product and is the usual substitute when BOP-like chemistry is wanted without the HMPA problem.
The rest of the family covers couplings where routine activation is too slow. According to the source, PyAOP is especially effective for couplings between N-methyl-protected amino acids, PyBrOP for sterically hindered amino acids such as N-methyl amino acids and α,α-dialkylglycines, and BOP-Cl for coupling Fmoc-α,α-dialkyl amino acids to tritylphenyl resins. The source credits the benzotriazole class as a whole with better coupling efficiency, fewer side reactions, and suppressed racemization for sterically hindered or sensitive amino acids, balanced against higher cost than carbodiimides alone and a need for careful handling and disposal.
The same stabilizing role is played by Oxyma , which the source groups with the benzotriazole derivatives. Structurally, Oxyma Pure is ethyl 2-cyano-2- hydroxyimino acetate, an oxime rather than a benzotriazole, so the grouping is a convenience of function, not of structure.
The source also places TBTU and EEDQ under the uronium heading, and that classification is chemically loose. TBTU is a genuine uronium salt, O- benzotriazol-1-yl -N,N,N',N'-tetramethyluronium tetrafluoroborate, which activates the carboxyl through a highly electrophilic uronium species and releases tetramethylurea. EEDQ, 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline, is a quinoline-based reagent that activates the carboxyl by forming a mixed carbonic anhydride, so the two should not be assumed to behave alike. The source describes the uronium salts as promoting fast, efficient peptide-bond formation, useful for low-solubility or challenging sequences, and producing fewer side products, but also as expensive, prone to contaminating products if not carefully controlled, and limited by resin or reagent compatibility.
The phosgene family , named in the source as chlorophosgene and triphosgene, activates a carboxyl by forming an acylated intermediate with the amino acid that reacts with the incoming amine. The practical member of the family is triphosgene, bis trichloromethyl carbonate, a crystalline, weighable surrogate for the parent compound phosgene carbonyl dichloride . The source credits these reagents with efficiency, good results on challenging amino acids, high yields, and minimal racemization and side reactions, but their toxicity dominates the practical picture: they are hazardous, comparatively expensive, and require specialized equipment for handling and disposal, which rules them out as a routine choice for most SPPS laboratories.
Mixed anhydrides are a different activation logic. An amino acid is converted by an acid chloride or acylating agent into a mixed anhydride, a reactive intermediate with two carbonyls; the amine attacks the amino-acid carbonyl to form the peptide bond while the other carbonyl leaves as an ester plus carbon dioxide. The source describes the method as effective, especially combined with HOBt or pyridine, and versatile across amino acids. But the intermediate is highly reactive: side reactions appear when conditions are not tightly controlled, and the preparation is more complex than dissolving a preformed reagent. Mixed anhydrides have largely been displaced by carbodiimide and phosphonium chemistry for routine SPPS, but they remain a recognized option.
The comparisons so far are qualitative. The source gives no yields, purities, doses, or dates, so any ranking of DIC/HOBt against TBTU against triphosgene has to be validated empirically on the target peptide. The peer-reviewed literature supplies some of the missing evidence, at least for the newest activation chemistries, and that evidence is worth weighing before a laboratory invests in a particular system.
A 2024 review of the past decade in asymmetric amide and peptide synthesis catalogs several racemization-free coupling reagents, including ynamides, allenones, metal alkoxides, and TCFH-NMI, and positions them as greener alternatives to conventional condensation reagents PMID 38775347 . The demonstrations behind that review are concrete. Allenones couple amino acids through an α-carbonyl vinyl ester intermediate without racemization or epimerization, and have been used in fragment condensation, in solid-phase synthesis, and in the syntheses of carfilzomib and the difficult acyl carrier protein 65-74 peptide PMID 34191506 . An ynamide reagent combined with a transient protection strategy has achieved one-pot inverse N-to-C peptide synthesis from formally unprotected amino acids, avoiding separate N-protection steps and finding use in active pharmaceutical ingredients, fragment condensation, and solid-phase synthesis PMID 38316681 . These are proof-of-performance studies on difficult targets, not systematic head-to-head benchmarks against the traditional reagents, but they show that racemization-free activation is experimentally real.
The wider literature confirms that condensation chemistry still reaches beyond standard amide bonds. A 2021 review catalogs the synthetic routes to sulfonopeptides, sulfur-containing peptide analogs whose tetrahedral sulfonamide groups mimic hydrolysis transition states, and condensation is one of the recognized routes PMID 33913204 . For bioconjugation, a lysine side-chain ε-amino group has been condensed directly with a thioester-modified oligodeoxynucleotide, with 2-sulfanylmethyl-4-dimethylaminopyridine accelerating the reaction under mild conditions enough to work with unprotected amino acids and with linear or cyclic peptides PMID 42219707 . At the far end of the spectrum, the modular PALME enzymatic platform has demonstrated sequence-unconstrained, traceless protein synthesis that bypasses chemical coupling reagents altogether, producing bioactive targets including pharmaceutical ingredients PMID 35663243 . None of this displaces the carbodiimide and phosphonium workhorses for routine SPPS, but it defines where the field is moving, and it means claims about any single green reagent should be checked against published data rather than taken on faith.
The decision logic follows from the chemistry. For routine couplings of standard Fmoc-protected amino acids to an unhindered resin-bound chain, use DIC plus an equivalent amount of HOBt rather than DCC, because DCC's dicyclohexylurea precipitates while DIC's urea stays in solution and is removed by the washes that follow each coupling. Where a water wash is part of the work-up, as in protein modification, EDCI is the carbodiimide of choice because both the reagent and its urea are water-soluble. For sequences containing asparagine or glutamine, avoid plain carbodiimide activation, since the nitrile dehydration side reaction is a known hazard, and OBt ester chemistry such as BOP or PyBOP avoids it. For the harder couplings, the mapping of situation to reagent is specific.
| Coupling situation | Reagent |
|---|---|
| Couplings between N-methyl-protected amino acids | PyAOP |
| N-methyl amino acids and α,α-dialkylglycines | PyBrOP |
| Fmoc-α,α-dialkyl amino acids on tritylphenyl resins | BOP-Cl |
| Difficult or low-solubility sequences needing fast coupling | TBTU |
| Challenging amino acids where toxicity protocols are in place | Triphosgene |
Two rules of thumb apply across all of these. If BOP's efficiency is attractive, use PyBOP instead: the efficiency is comparable and the by-product risk is far lower, because BOP generates the carcinogen HMPA. Wash the resin after every coupling and deprotection step; most by-products and excess reagents are soluble under the wash conditions, and the washes keep the growing chain free of the contaminants that reagent choice is meant to avoid.
Because the available comparisons are qualitative, the final step in any reagent selection is empirical. Run the difficult couplings on a test portion of the resin, monitor them by HPLC or mass spectrometry, and check the final peptide for epimerized diastereomers, especially at residues coupled after hindered positions or near the C-terminus. No reagent choice removes the need for that check.
Four caveats attach to the source material behind this survey. It is qualitative only: no yields, purities, doses, or dates, and no stoichiometry, concentration, time, or temperature recommendations for any reagent. It gives two different full chemical names for BOP, so the abbreviation's exact identity is internally inconsistent and must be verified before ordering. It classifies EEDQ and TBTU together as uronium salts, which is chemically inaccurate for EEDQ, and it lists Oxyma under benzotriazole derivatives while describing Oxyma Pure as a derivative of HOBt, when the compound is an oxime. The claim that Oxyma Pure has gained popularity rests on no comparative data in the source.
What remains unresolved is mostly quantitative. There is no public dataset ranking condensation agents by yield, racemization, cost, and resin compatibility across a defined panel of peptides. The recommended reaction conditions for each reagent are not systematically reported. The best match of reagent family to Fmoc/tBu versus Boc/Bzl strategies, and the effect of resin type on that match, have not been established. The practical preparation of mixed anhydrides without side reactions remains more craft than protocol. The newer reagents demonstrated in the recent literature answer part of that gap, but a chemist choosing between a traditional carbodiimide and an allenone still has to generate the comparison on the bench.
The practical conclusion is short. Start with DIC and an equivalent amount of HOBt. Escalate to the specialist phosphonium or uronium reagents only when the sequence demands it. Treat qualitative claims, including claims of popularity for any particular green additive, as hypotheses to test rather than as data. Measure the outcome: yield, purity, and epimer content are the only arbiters that matter.
PMID 38775347 - Recent advances in asymmetric synthesis of chiral amides and peptides: racemization-free coupling reagents. Organic & biomolecular chemistry, 2024. https://pubmed.ncbi.nlm.nih.gov/38775347/
PMID 34191506 - Allenone-Mediated Racemization/Epimerization-Free Peptide Bond Formation and Its Application in Peptide Synthesis. Journal of the American Chemical Society, 2021. https://pubmed.ncbi.nlm.nih.gov/34191506/
PMID 38316681 - Inverse Peptide Synthesis Using Transient Protected Amino Acids. Journal of the American Chemical Society, 2024. https://pubmed.ncbi.nlm.nih.gov/38316681/
PMID 33913204 - Synthesis of sulfonopeptides. Journal of peptide science : an official publication of the European Peptide Society, 2021. https://pubmed.ncbi.nlm.nih.gov/33913204/
PMID 42219707 - Synthesis of Peptide-Oligonucleotide Conjugates via Condensation of a Lysine Side-Chain with a Thioester. The Journal of organic chemistry, 2026. https://pubmed.ncbi.nlm.nih.gov/42219707/
PMID 35663243 - Traceless enzymatic protein synthesis without ligation sites constraint. National science review, 2022. https://pubmed.ncbi.nlm.nih.gov/35663243/
Related reading: Enzyme classes for biocatalytic synthesis of short oligopeptides, AI-Guided Peptide Library Design: Capabilities and Outcomes, How Chameleon Cyclic Peptides Cross Membranes for Oral Drugs, Five Enzymatic Routes to Oligopeptides and Short Peptide Synthesis.